normal tissue data Search Results


90
Human Protein Atlas mrna expression data for 37 different normal tissues
Mrna Expression Data For 37 Different Normal Tissues, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/mrna+expression+data+for+37+different+normal+tissues/pmc07904710-43-10-17
Average 90 stars, based on 1 article reviews
mrna expression data for 37 different normal tissues - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas normal tissue data
Normal Tissue Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/normal+tissue+data/pmc07212270__mmc3-559-10-7
Average 90 stars, based on 1 article reviews
normal tissue data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas hcc and normal liver tissues expression data
Mutational landscape of <t>SMGs</t> <t>in</t> <t>HCC.</t> (A) Significantly mutated genes in HCC. The different colors represent different mutation types. (B) Expression of SMGs in HCC and normal tissues. According to an analysis of immunohistochemical staining data from the Human Protein Atlas database, the expression of SMGs in HCC was compared with that in normal tissues.
Hcc And Normal Liver Tissues Expression Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/hcc+and+normal+liver+tissues+expression+data/pmc07330124-139-8-16
Average 90 stars, based on 1 article reviews
hcc and normal liver tissues expression data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Broad Institute Inc poly(a)+ rna-seq data for normal healthy tissues
Mutational landscape of <t>SMGs</t> <t>in</t> <t>HCC.</t> (A) Significantly mutated genes in HCC. The different colors represent different mutation types. (B) Expression of SMGs in HCC and normal tissues. According to an analysis of immunohistochemical staining data from the Human Protein Atlas database, the expression of SMGs in HCC was compared with that in normal tissues.
Poly(a)+ Rna Seq Data For Normal Healthy Tissues, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/poly+a+++rna+seq+data+for+normal+healthy+tissues/pmc08919705-279-1-12
Average 90 stars, based on 1 article reviews
poly(a)+ rna-seq data for normal healthy tissues - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas normal tissue scrnaseq data
Mutational landscape of <t>SMGs</t> <t>in</t> <t>HCC.</t> (A) Significantly mutated genes in HCC. The different colors represent different mutation types. (B) Expression of SMGs in HCC and normal tissues. According to an analysis of immunohistochemical staining data from the Human Protein Atlas database, the expression of SMGs in HCC was compared with that in normal tissues.
Normal Tissue Scrnaseq Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/normal+tissue+scrnaseq+data/pm37802054-250-6-11
Average 90 stars, based on 1 article reviews
normal tissue scrnaseq data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas normal tissue fpkm data
Mutational landscape of <t>SMGs</t> <t>in</t> <t>HCC.</t> (A) Significantly mutated genes in HCC. The different colors represent different mutation types. (B) Expression of SMGs in HCC and normal tissues. According to an analysis of immunohistochemical staining data from the Human Protein Atlas database, the expression of SMGs in HCC was compared with that in normal tissues.
Normal Tissue Fpkm Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/normal+tissue+fpkm+data/pmc11994455-462-0-8
Average 90 stars, based on 1 article reviews
normal tissue fpkm data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas immunohistochemistry data of args in normal lung tissue and lusc tumor tissue
Results of differentially expressed analysis on <t>ARGs</t> and enrichment analysis of DE‐ARGs. (A) A heatmap of 48 differentially expressed ARGs between <t>326</t> <t>LUSC</t> samples and 32 normal controls. Each line represents a DE‐ARG and each row means a sample. The expression levels of genes are displayed with colors in each cell (red for high and blue for low). (B) The volcano plot of differentially expressed ARGs between LUSC samples and normal controls. (C) The enriched significant KEGG signal pathways of DE‐ARGs. The color represents the statistical significance of the term. The length indicates the counts of enriched genes.
Immunohistochemistry Data Of Args In Normal Lung Tissue And Lusc Tumor Tissue, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/immunohistochemistry+data+of+args+in+normal+lung+tissue+and+lusc+tumor+tissue/pmc11499073-96-3-14
Average 90 stars, based on 1 article reviews
immunohistochemistry data of args in normal lung tissue and lusc tumor tissue - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas subcellular localization of tgif2 protein in sh-sy5y cell line
The expression level of <t>TGIF2</t> in different human cancers and its relationship to glioma prognosis. (A) TGIF2 mRNA expression across various human organs and tissues based on consensus dataset in HPA database. (B) Comparison of TGIF2 expression between normal and tumor tissues across 33 cancers in TCGA and the GTEx database. (C) Subcellular localization of TGIF2 in SH-SY5Y cells from HPA datasets. (D) The volcano plot of DEGs in GSE14805. Red points represent upregulated, blue points represents downregulated genes. (E) ROC curve of TGIF2 and other established prognostic genes (IDH1, IDH2, EGFR, TP53, CDC6, CDC14B, CHD5) in glioma. (F–H) Survival curves for OS (F) , DSS (G) and PFI (H) in gliomas using TCGA database. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Subcellular Localization Of Tgif2 Protein In Sh Sy5y Cell Line, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/mrna+expression+data+of+tgif2+in+normal+tissues/pmc11020094-123-13-22
Average 90 stars, based on 1 article reviews
subcellular localization of tgif2 protein in sh-sy5y cell line - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas immunohistochemical data of 9 hub genes in luad or normal lung tissue
The expression level of <t>TGIF2</t> in different human cancers and its relationship to glioma prognosis. (A) TGIF2 mRNA expression across various human organs and tissues based on consensus dataset in HPA database. (B) Comparison of TGIF2 expression between normal and tumor tissues across 33 cancers in TCGA and the GTEx database. (C) Subcellular localization of TGIF2 in SH-SY5Y cells from HPA datasets. (D) The volcano plot of DEGs in GSE14805. Red points represent upregulated, blue points represents downregulated genes. (E) ROC curve of TGIF2 and other established prognostic genes (IDH1, IDH2, EGFR, TP53, CDC6, CDC14B, CHD5) in glioma. (F–H) Survival curves for OS (F) , DSS (G) and PFI (H) in gliomas using TCGA database. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Immunohistochemical Data Of 9 Hub Genes In Luad Or Normal Lung Tissue, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/immunohistochemical+data+of+9+hub+genes+in+luad+or+normal+lung+tissue/pmc08841557-96-8-17
Average 90 stars, based on 1 article reviews
immunohistochemical data of 9 hub genes in luad or normal lung tissue - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GenXPro Inc super-sage data for malat1 expression in pancreas carcinoma and pancreatitis compared to normal pancreas tissue
The expression level of <t>TGIF2</t> in different human cancers and its relationship to glioma prognosis. (A) TGIF2 mRNA expression across various human organs and tissues based on consensus dataset in HPA database. (B) Comparison of TGIF2 expression between normal and tumor tissues across 33 cancers in TCGA and the GTEx database. (C) Subcellular localization of TGIF2 in SH-SY5Y cells from HPA datasets. (D) The volcano plot of DEGs in GSE14805. Red points represent upregulated, blue points represents downregulated genes. (E) ROC curve of TGIF2 and other established prognostic genes (IDH1, IDH2, EGFR, TP53, CDC6, CDC14B, CHD5) in glioma. (F–H) Survival curves for OS (F) , DSS (G) and PFI (H) in gliomas using TCGA database. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Super Sage Data For Malat1 Expression In Pancreas Carcinoma And Pancreatitis Compared To Normal Pancreas Tissue, supplied by GenXPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/super+sage+data+for+malat1+expression+in+pancreas+carcinoma+and+pancreatitis+compared+to+normal+pancreas+tissue/pmc03661464-101-9-18
Average 90 stars, based on 1 article reviews
super-sage data for malat1 expression in pancreas carcinoma and pancreatitis compared to normal pancreas tissue - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas normal tissue ihc data v.23.0
(A &B) Contingency tables used to determine the likelihood of detecting a clinical (A) ADC and (B) CAR T target in the PDX human tumor N -glycoproteome against all other surface proteins in the human proteome. P-values were calculated using a Fisher’s exact test. (C) Normal tissue toxicity scoring system. (D) Distribution of full body normal tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Jiang et al., (left), Human Protein Atlas (middle) and GTEx RNA-seq data (right). (E) Distribution of normal brain tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Tushaus et al., (left), Human Protein Atlas brain <t>IHC</t> <t>data</t> (middle) and Human Protein Atlas brain RNA-seq data (right). (F) Distribution of normal heart tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Berg Luecke et al., (left) and Doll et al., (middle & right). (D-F) P-values from unpaired Mann-Whitney U tests.
Normal Tissue Ihc Data V.23.0, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/normal+tissue+ihc+data+v+23+0/bio_rxiv__2024__12__11__627962-372-0-7
Average 90 stars, based on 1 article reviews
normal tissue ihc data v.23.0 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Human Protein Atlas immunohistochemical data of breast cancer and normal tissues
(A &B) Contingency tables used to determine the likelihood of detecting a clinical (A) ADC and (B) CAR T target in the PDX human tumor N -glycoproteome against all other surface proteins in the human proteome. P-values were calculated using a Fisher’s exact test. (C) Normal tissue toxicity scoring system. (D) Distribution of full body normal tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Jiang et al., (left), Human Protein Atlas (middle) and GTEx RNA-seq data (right). (E) Distribution of normal brain tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Tushaus et al., (left), Human Protein Atlas brain <t>IHC</t> <t>data</t> (middle) and Human Protein Atlas brain RNA-seq data (right). (F) Distribution of normal heart tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Berg Luecke et al., (left) and Doll et al., (middle & right). (D-F) P-values from unpaired Mann-Whitney U tests.
Immunohistochemical Data Of Breast Cancer And Normal Tissues, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+tissue+data/immunohistochemical+data+of+breast+cancer+and+normal+tissues/pmc04813709-374-3-11
Average 90 stars, based on 1 article reviews
immunohistochemical data of breast cancer and normal tissues - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Mutational landscape of SMGs in HCC. (A) Significantly mutated genes in HCC. The different colors represent different mutation types. (B) Expression of SMGs in HCC and normal tissues. According to an analysis of immunohistochemical staining data from the Human Protein Atlas database, the expression of SMGs in HCC was compared with that in normal tissues.

Journal: Frontiers in Genetics

Article Title: Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes

doi: 10.3389/fgene.2020.00634

Figure Lengend Snippet: Mutational landscape of SMGs in HCC. (A) Significantly mutated genes in HCC. The different colors represent different mutation types. (B) Expression of SMGs in HCC and normal tissues. According to an analysis of immunohistochemical staining data from the Human Protein Atlas database, the expression of SMGs in HCC was compared with that in normal tissues.

Article Snippet: After identifying SMGs, we obtained the expression of SMGs in HCC and normal liver tissues in Human Protein Atlas database ( https://www.proteinatlas.org/ ).

Techniques: Mutagenesis, Expressing, Immunohistochemical staining, Staining

Mutation signatures operative in HCC. (A) Single nucleotide variation classification: different colors represent different types of variation. (B) Variant classification: different colors represent different variant classifications. (C) Mutational signatures: spectrum of total SNVs and three mutational signatures in the context of the 96 base-pair substitutions. Because the dynamic range for the signatures is large, the upper limits of the y-axis used for each signature are different. (D) SMG mutation rate in three groups of HCC samples. (E) Unsupervised clustering of mutations in SMGs and focal SCNAs. (F) Differences in mutational patterns between APOBEC-enriched and non-APOBEC-enriched samples.

Journal: Frontiers in Genetics

Article Title: Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes

doi: 10.3389/fgene.2020.00634

Figure Lengend Snippet: Mutation signatures operative in HCC. (A) Single nucleotide variation classification: different colors represent different types of variation. (B) Variant classification: different colors represent different variant classifications. (C) Mutational signatures: spectrum of total SNVs and three mutational signatures in the context of the 96 base-pair substitutions. Because the dynamic range for the signatures is large, the upper limits of the y-axis used for each signature are different. (D) SMG mutation rate in three groups of HCC samples. (E) Unsupervised clustering of mutations in SMGs and focal SCNAs. (F) Differences in mutational patterns between APOBEC-enriched and non-APOBEC-enriched samples.

Article Snippet: After identifying SMGs, we obtained the expression of SMGs in HCC and normal liver tissues in Human Protein Atlas database ( https://www.proteinatlas.org/ ).

Techniques: Mutagenesis, Variant Assay

Results of differentially expressed analysis on ARGs and enrichment analysis of DE‐ARGs. (A) A heatmap of 48 differentially expressed ARGs between 326 LUSC samples and 32 normal controls. Each line represents a DE‐ARG and each row means a sample. The expression levels of genes are displayed with colors in each cell (red for high and blue for low). (B) The volcano plot of differentially expressed ARGs between LUSC samples and normal controls. (C) The enriched significant KEGG signal pathways of DE‐ARGs. The color represents the statistical significance of the term. The length indicates the counts of enriched genes.

Journal: Cancer Reports

Article Title: A Four‐Gene Autophagy‐Related Prognostic Model Signature and Its Association With Immune Phenotype in Lung Squamous Cell Carcinoma

doi: 10.1002/cnr2.70000

Figure Lengend Snippet: Results of differentially expressed analysis on ARGs and enrichment analysis of DE‐ARGs. (A) A heatmap of 48 differentially expressed ARGs between 326 LUSC samples and 32 normal controls. Each line represents a DE‐ARG and each row means a sample. The expression levels of genes are displayed with colors in each cell (red for high and blue for low). (B) The volcano plot of differentially expressed ARGs between LUSC samples and normal controls. (C) The enriched significant KEGG signal pathways of DE‐ARGs. The color represents the statistical significance of the term. The length indicates the counts of enriched genes.

Article Snippet: Immunohistochemistry data of ARGs in normal lung tissue and LUSC tumor tissue from The Human Protein Atlas project are also included (Figure ).

Techniques: Expressing

The expression level of TGIF2 in different human cancers and its relationship to glioma prognosis. (A) TGIF2 mRNA expression across various human organs and tissues based on consensus dataset in HPA database. (B) Comparison of TGIF2 expression between normal and tumor tissues across 33 cancers in TCGA and the GTEx database. (C) Subcellular localization of TGIF2 in SH-SY5Y cells from HPA datasets. (D) The volcano plot of DEGs in GSE14805. Red points represent upregulated, blue points represents downregulated genes. (E) ROC curve of TGIF2 and other established prognostic genes (IDH1, IDH2, EGFR, TP53, CDC6, CDC14B, CHD5) in glioma. (F–H) Survival curves for OS (F) , DSS (G) and PFI (H) in gliomas using TCGA database. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: The expression level of TGIF2 in different human cancers and its relationship to glioma prognosis. (A) TGIF2 mRNA expression across various human organs and tissues based on consensus dataset in HPA database. (B) Comparison of TGIF2 expression between normal and tumor tissues across 33 cancers in TCGA and the GTEx database. (C) Subcellular localization of TGIF2 in SH-SY5Y cells from HPA datasets. (D) The volcano plot of DEGs in GSE14805. Red points represent upregulated, blue points represents downregulated genes. (E) ROC curve of TGIF2 and other established prognostic genes (IDH1, IDH2, EGFR, TP53, CDC6, CDC14B, CHD5) in glioma. (F–H) Survival curves for OS (F) , DSS (G) and PFI (H) in gliomas using TCGA database. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques: Expressing, Comparison

Clinical characteristics of glioma patients.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: Clinical characteristics of glioma patients.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques:

Logistic analysis of the association between  TGIF2  expression and clinical characteristics.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: Logistic analysis of the association between TGIF2 expression and clinical characteristics.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques: Expressing

Associations between TGIF2 expression and various clinicopathologic characteristics in glioma. (A) Age. (B) IDH status. (C) 1p/19q codeletion status. (D) Primary therapy outcome. (E) OS events. (F) DSS events. (G) PFI events. (H) WHO grade. (I) Histological type. (J) Gender. (K) Race. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ns, not significant.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: Associations between TGIF2 expression and various clinicopathologic characteristics in glioma. (A) Age. (B) IDH status. (C) 1p/19q codeletion status. (D) Primary therapy outcome. (E) OS events. (F) DSS events. (G) PFI events. (H) WHO grade. (I) Histological type. (J) Gender. (K) Race. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ns, not significant.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques: Expressing

Prognostic value of TGIF2 expression level in glioma. (A) TGIF2 expression distribution and survival status. (B) Time-dependent ROC curves for TGIF2 expression in glioma. (C) Forest plot of OS by multivariate Cox regression analysis in glioma from TCGA database. (D) The nomogram for predicting 1-, 3-, or 5-year OS rates in patients with glioma. (E) The calibration curves for the nomogram.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: Prognostic value of TGIF2 expression level in glioma. (A) TGIF2 expression distribution and survival status. (B) Time-dependent ROC curves for TGIF2 expression in glioma. (C) Forest plot of OS by multivariate Cox regression analysis in glioma from TCGA database. (D) The nomogram for predicting 1-, 3-, or 5-year OS rates in patients with glioma. (E) The calibration curves for the nomogram.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques: Expressing

Univariate and multivariate cox regression analyses of clinical characteristics associated with overall survival.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: Univariate and multivariate cox regression analyses of clinical characteristics associated with overall survival.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques:

Correlations between TGIF2 expression level and OS in different clinicopathologic subgroups of glioma by Kaplan-Meier survival curve analysis. (A) Age ≤ 60. (B) Age > 60. (C) Gender: Male. (D) Gender: Female. (E) Race: White. (F) WHO grade: G3. (G) 1p/19q codeletion: non-codeletion. (H) Histological type: Astrocytoma. (I) Primary therapy outcome: PD.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: Correlations between TGIF2 expression level and OS in different clinicopathologic subgroups of glioma by Kaplan-Meier survival curve analysis. (A) Age ≤ 60. (B) Age > 60. (C) Gender: Male. (D) Gender: Female. (E) Race: White. (F) WHO grade: G3. (G) 1p/19q codeletion: non-codeletion. (H) Histological type: Astrocytoma. (I) Primary therapy outcome: PD.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques: Expressing

Functional enrichment analysis of DEGs between TGIF2 high and low expression groups. (A) The volcano plot of DEGs. Red represents upregulated, blue represents downregulated genes. (B) GO and KEGG pathway enrichment analysis of DEGs. (C–H) GSEA functional enrichment analysis.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: Functional enrichment analysis of DEGs between TGIF2 high and low expression groups. (A) The volcano plot of DEGs. Red represents upregulated, blue represents downregulated genes. (B) GO and KEGG pathway enrichment analysis of DEGs. (C–H) GSEA functional enrichment analysis.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques: Functional Assay, Expressing

Correlations between TGIF2 expression and immune cell infiltration in glioma. (A–C) Comparison of StromalScore, ImmuneScore, and EstimateScore between TGIF2 high and low expression groups. (D, E) Comparison of immune cell enrichment scores in high and low TGIF2 expression groups. (F) The lollipop chart showing the correlations between the relative abundances of 24 immune cells and TGIF2 expression levels. (G–N) Scatterplots demonstrating the positive correlation of TGIF2 expression with Th2 cells, macrophages, eosinophils, and neutrophils, and the negative correlation with mast cells, NK CD56bright cells, pDC cells, and TFH cells. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ns, not significant.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: Correlations between TGIF2 expression and immune cell infiltration in glioma. (A–C) Comparison of StromalScore, ImmuneScore, and EstimateScore between TGIF2 high and low expression groups. (D, E) Comparison of immune cell enrichment scores in high and low TGIF2 expression groups. (F) The lollipop chart showing the correlations between the relative abundances of 24 immune cells and TGIF2 expression levels. (G–N) Scatterplots demonstrating the positive correlation of TGIF2 expression with Th2 cells, macrophages, eosinophils, and neutrophils, and the negative correlation with mast cells, NK CD56bright cells, pDC cells, and TFH cells. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ns, not significant.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques: Expressing, Comparison

Analysis of genes coexpressed with TGIF2 in glioma. (A) Heatmap showing the 30 genes in glioma that were 15 positively and 15 negatively related to TGIF2. (B) PPI network of top 50 protein-coding genes positively and negatively correlated with TGIF2. (C) The top 10 hub genes of the PPI network in (B) . (D) The expression levels of the top 10 hub genes in normal and glioma tissues in TCGA and GTEx database. ∗∗∗p < 0.001.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: Analysis of genes coexpressed with TGIF2 in glioma. (A) Heatmap showing the 30 genes in glioma that were 15 positively and 15 negatively related to TGIF2. (B) PPI network of top 50 protein-coding genes positively and negatively correlated with TGIF2. (C) The top 10 hub genes of the PPI network in (B) . (D) The expression levels of the top 10 hub genes in normal and glioma tissues in TCGA and GTEx database. ∗∗∗p < 0.001.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques: Expressing

Knockdown of TGIF2 inhibits glioma cell invasion, migration and EMT in vitro . (A) Bar graph demonstrating the efficiency of siRNA knockdown of TGIF2 mRNA in U251 cells by RT-qPCR. (B) Western blot assay showing that siRNA effectively knocked down TGIF2 protein, and siTGIF2 downregulated N-cadherin protein expression in U251 cells. (C) Transwell assay demonstrating changes in the number of cells invaded after knockdown of TGIF2. Scale bar, 500 μm. (D) Scratch wound-healing assays were utilized to compare the distance of cell migration between TGIF2-inhibited group and control group at 0h and 24h after scratching. Scale bar, 500 μm. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: Knockdown of TGIF2 inhibits glioma cell invasion, migration and EMT in vitro . (A) Bar graph demonstrating the efficiency of siRNA knockdown of TGIF2 mRNA in U251 cells by RT-qPCR. (B) Western blot assay showing that siRNA effectively knocked down TGIF2 protein, and siTGIF2 downregulated N-cadherin protein expression in U251 cells. (C) Transwell assay demonstrating changes in the number of cells invaded after knockdown of TGIF2. Scale bar, 500 μm. (D) Scratch wound-healing assays were utilized to compare the distance of cell migration between TGIF2-inhibited group and control group at 0h and 24h after scratching. Scale bar, 500 μm. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques: Knockdown, Migration, In Vitro, Quantitative RT-PCR, Western Blot, Expressing, Transwell Assay, Control

Knockout of TGIF2 suppresses glioma cell invasion, migration and EMT. (A) The gRNA sequences designed targeting exon 2 of TGIF2. (B) The editing efficiency of gRNA33 and gRNA140 on TGIF2 was verified in 293T cells utilizing Sanger sequencing. (C) TGIF2-gRNA33 in the UCSC browser. (D) Western blot assay showing the knockout efficiency of TGIF2 protein. WT, Wild type; KO, Knockout. (E) Transwell assays showing changes in the number of cells invaded after knockout of TGIF2. Scale bar, 500 μm. (F) Scratch wound-healing assays were utilized to compare the distance of cell migration between TGIF2-knockout group and control group at 0h and 24h after scratching. Scale bar, 250 μm. ∗p < 0.05.

Journal: Frontiers in Immunology

Article Title: TGIF2 is a potential biomarker for diagnosis and prognosis of glioma

doi: 10.3389/fimmu.2024.1356833

Figure Lengend Snippet: Knockout of TGIF2 suppresses glioma cell invasion, migration and EMT. (A) The gRNA sequences designed targeting exon 2 of TGIF2. (B) The editing efficiency of gRNA33 and gRNA140 on TGIF2 was verified in 293T cells utilizing Sanger sequencing. (C) TGIF2-gRNA33 in the UCSC browser. (D) Western blot assay showing the knockout efficiency of TGIF2 protein. WT, Wild type; KO, Knockout. (E) Transwell assays showing changes in the number of cells invaded after knockout of TGIF2. Scale bar, 500 μm. (F) Scratch wound-healing assays were utilized to compare the distance of cell migration between TGIF2-knockout group and control group at 0h and 24h after scratching. Scale bar, 250 μm. ∗p < 0.05.

Article Snippet: The mRNA expression data of TGIF2 in normal tissues and subcellular localization of TGIF2 protein in SH-SY5Y cell line were sourced from Human Protein Atlas (HPA) database ( http://www.proteinatlas.org/ ).

Techniques: Knock-Out, Migration, Sequencing, Western Blot, Control

(A &B) Contingency tables used to determine the likelihood of detecting a clinical (A) ADC and (B) CAR T target in the PDX human tumor N -glycoproteome against all other surface proteins in the human proteome. P-values were calculated using a Fisher’s exact test. (C) Normal tissue toxicity scoring system. (D) Distribution of full body normal tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Jiang et al., (left), Human Protein Atlas (middle) and GTEx RNA-seq data (right). (E) Distribution of normal brain tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Tushaus et al., (left), Human Protein Atlas brain IHC data (middle) and Human Protein Atlas brain RNA-seq data (right). (F) Distribution of normal heart tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Berg Luecke et al., (left) and Doll et al., (middle & right). (D-F) P-values from unpaired Mann-Whitney U tests.

Journal: bioRxiv

Article Title: Pan-cancer N -glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers

doi: 10.1101/2024.12.11.627962

Figure Lengend Snippet: (A &B) Contingency tables used to determine the likelihood of detecting a clinical (A) ADC and (B) CAR T target in the PDX human tumor N -glycoproteome against all other surface proteins in the human proteome. P-values were calculated using a Fisher’s exact test. (C) Normal tissue toxicity scoring system. (D) Distribution of full body normal tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Jiang et al., (left), Human Protein Atlas (middle) and GTEx RNA-seq data (right). (E) Distribution of normal brain tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Tushaus et al., (left), Human Protein Atlas brain IHC data (middle) and Human Protein Atlas brain RNA-seq data (right). (F) Distribution of normal heart tissue abundance or detection frequency of PDX target candidates (purple) vs solid tumor clinical immunotherapy targets (grey) in Berg Luecke et al., (left) and Doll et al., (middle & right). (D-F) P-values from unpaired Mann-Whitney U tests.

Article Snippet: Normal tissue IHC data were downloaded from Human Protein Atlas (v.23.0) .

Techniques: Glycoproteomics, RNA Sequencing, MANN-WHITNEY